Ancora Heart Announces Positive Interim Analysis from Study of First-of-Its-Kind Heart Failure Therapy

Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair

MHIF Treats First Patient in AccuCinch Study for Mitral Regurgitation and Heart Failure

Ancora Heart Enrolls First Patient in U.S. Early Feasibility Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart Enrolls First Patient in European Multi-Center Study of First-of-Its-Kind Investigational Heart Failure Therapy

The Christ Hospital Health Network First in Ohio to Use New Minimally Invasive Approach for Treating Heart Failure

First Belarusian patients implanted with an innovative device for the treatment of heart failure

Ancora Heart Announces Positive Safety and Efficacy Data from Study of First-of-Its-Kind Investigational Heart Failure Therapy

Ancora Heart sees positive early results with Accucinch in systolic heart failure

Tales from TCT 2019: Ancora’s Heart Felt Data

To Learn More

GET IN TOUCH